On February 23, 2026 Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) ("Ascentage Pharma" or the "Company, a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, reported that the Company’s management is scheduled to participate in three upcoming investor conferences.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
● Oppenheimer 36th Annual Healthcare Life Sciences Conference: Presentation at 9:20 am EST on February 25th
● TD Cowen 46th Annual Health Care Conference: Fireside chat at 9:50 am EST on March 4th
● Jefferies Biotech on the Beach Summit: One-on-one meetings on March 10th & 11th
The webcasts for the presentation and fireside chat will be accessed by visiting the Events page in the Investor Relations section of Ascentage’s website.
(Press release, Ascentage Pharma, FEB 23, 2026, View Source [SID1234662843])